Strategic objectives 

Generation and validation of useful tools for the diagnosis, prognosis, stratification and treatment of patients with various pathologies.

Research lines

• Mechanisms of renal fibrosis development. New biomarkers and targets for therapeutic action in chronic kidney disease.
• Mechanisms of macrophage polarisation in nephropathies: potential new therapeutic approaches in renal inflammation.
• Physiopathological mechanisms in minority nephropathies: characterisation and new tools for patient stratification.
• Physiopathological mechanisms and new useful biomarkers in renal cancer: patient stratification for personalised therapy.
• miRNAs and incRNAS as new diagnostic and prognostic biomarkers in pancreatic cancer.
• New targets for therapeutic action in pancreatic cancer according to tumour subtype: KIF3B.
• miRNAs as biomarkers in heart failure and cardiac remodelling mechanisms: cardio-renal axis.
• miRNAs as stratification tools and new targets for therapeutic action in colorectal cancer.